Professor, Chair of Stem Cell Sciences, Program Leader, Stem Cells Australia, The University of Melbourne, Walter and Eliza Hall Institute of Medical Research, Florey Neuroscience and Mental
Using human pluripotent stem cells as a screening platform, we have identified a novel cell surface maker that identifies foregut endoderm progenitors in pancreas and liver. We have shown that cells of the biliary reaction, a regenerative response to liver damage, premalignant and pancreatic ductal adenocarcinoma cells, and the columnar epithelium of Barrett’s Oesophagus, a preneoplastic precursor of oesophageal carcinoma, all express this antigen on their surface. The antigen is expressed in liver and pancreas during development, and is also found in the serum of patients with pancreatic or liver cancer. Cell surface antigens expressed on fetal stem or progenitors cells provide biomarkers of tissue regenerative processes, and can be used to monitor progression neoplasia if repair processes fail to resolve the underlying pathology.
Long-read sequencing is transforming the landscape of genomic research, offering exceptional resolution and accuracy in the analysis of complex genetic structures. From research in genetic a...
Biosafety cabinets (BSCs) are a cornerstone of modern laboratory safety, yet many users lack a clear understanding of how they work, how to use them properly, and how to distinguish between...
Laboratories are under growing pressure to meet both stringent safety standards and ambitious sustainability goals—often with limited resources. This webinar, hosted by Erlab, a global...
CAR-T Therapy continues to evolve rapidly, mRNA encoding CAR constructs directly to T cells in the bloodstream, potentially enabling CAR T cell production in the body without the need to iso...
The analysis of protein behavior and protein interactions is central in drug research. In this web seminar, we will show you how the automation of protein purification and downstream thermal...
This presentation explores the scientific rationale, preclinical validation, and early clinical translation of STAR-LLD—a novel, continuous low-dose percutaneous lenalidomide delivery...
Loading Comments...
Please update your information
Certificate of Participation
Thank you for choosing Labroots. Please note that a Certificate of Participation does NOT count towards Continuing Education Credits.